Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free ABT Stock Alerts

Abbott Laboratories (ABT) Short Interest Ratio & Short Volume

Abbott Laboratories logo
$116.62 +2.48 (+2.17%)
As of 08/21/2026 03:58 PM Eastern
Compare

Abbott Laboratories Short Interest Overview

As of July 31, 2026, Abbott Laboratories (ABT) had a short interest of 22.62 million shares sold short, representing 1.31% of the public float. This marks a -8.94% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.7, meaning it would take 1.7 days of the average trading volume of 8.52 million shares to cover all short positions.

Current Short Interest
22,624,184 shares
Previous Short Interest
24,846,147 shares
Change Vs. Previous Month
-8.94%
Dollar Volume Sold Short
$2.40 billion
Short Interest Ratio
1.7 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
1,730,380,000 shares
Short Percent of Float
1.31%
Today's Trading Volume
9,834,559 shares
Average Trading Volume
8,517,958 shares
Today's Volume Vs. Average
115%
Short Selling Abbott Laboratories?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABT Short Interest Over Time

ABT Days to Cover Over Time

ABT Percentage of Float Shorted Over Time

Abbott Laboratories Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202622,624,184 shares $2.40 billion -8.9%1.3%1.66 $105.99
7/15/202624,846,147 shares $2.22 billion +6.2%1.4%2.14 $89.27
6/30/202623,387,895 shares $2.12 billion +6.4%1.3%1.48 $90.68
6/15/202621,974,266 shares $1.95 billion -0.3%1.3%1.77 $88.76
5/29/202622,044,423 shares $1.88 billion -5.1%1.3%1.94 $85.36
5/15/202623,222,031 shares $1.96 billion +3.0%1.3%1.7 $84.49
4/30/202622,536,486 shares $2.05 billion +3.6%1.3%1.5 $90.75
4/15/202621,746,613 shares $2.21 billion -8.7%1.3%2.26 $101.55
3/31/202623,825,745 shares $2.44 billion +19.4%1.4%1.56 $102.59
3/13/202619,950,568 shares $2.15 billion +9.4%1.2%2.26 $107.99
2/27/202618,233,629 shares $2.12 billion +6.0%1.1%2.21 $116.17
2/13/202617,198,525 shares $1.94 billion -8.2%1.0%1.52 $112.63
1/30/202618,726,478 shares $2.05 billion -6.0%1.1%1.05 $109.31
1/15/202619,914,580 shares $2.46 billion +14.5%1.2%3.31 $123.49
12/31/202517,399,553 shares $2.18 billion +9.6%1.0%3 $125.30
12/15/202515,875,548 shares $2.04 billion -14.1%0.9%2.82 $128.58
11/28/202518,485,281 shares $2.38 billion -3.4%1.1%2.25 $128.90
11/14/202519,141,411 shares $2.50 billion -5.1%1.1%3.62 $130.59
10/31/202520,171,849 shares $2.49 billion +4.2%1.2%3.3 $123.61
10/15/202519,360,000 shares $2.50 billion +6.6%1.1%3.3 $129.35
9/30/202518,170,000 shares $2.43 billion +0.6%1.1%2.9 $133.97
9/15/202518,070,000 shares $2.37 billion +1.8%1.0%2.8 $131.40
8/31/202517,750,000 shares $2.35 billion +3.7%1.0%2.8 $132.59
8/15/202517,110,000 shares $2.25 billion -6.7%1.0%2.7 $131.66
7/31/202518,330,000 shares $2.31 billion -3.8%1.1%2.8 $126.16
7/15/202519,060,000 shares $2.50 billion -1.9%1.1%2.8 $131.41
6/30/202519,430,000 shares $2.64 billion -6.6%1.1%2.9 $136.09
6/15/202520,800,000 shares $2.82 billion +3.5%1.2%3.1 $135.41
5/31/202520,090,000 shares $2.69 billion -9.8%1.2%2.9 $133.68
5/15/202522,260,000 shares $2.97 billion +5.4%1.3%3.1 $133.39
4/30/202521,120,000 shares $2.76 billion -2.6%1.2%3 $130.71
4/15/202521,690,000 shares $2.73 billion -0.5%1.3%2.9 $126.08
3/31/202521,790,000 shares $2.89 billion -0.4%1.3%3.1 $132.76
3/15/202521,880,000 shares $2.78 billion -4.6%1.3%3.3 $127.02
2/28/202522,930,000 shares $3.16 billion +2.8%1.3%3.7 $137.99
2/15/202522,310,000 shares $2.91 billion +22.3%1.3%3.9 $130.63
1/31/202518,240,000 shares $2.33 billion +21.8%1.1%3.2 $127.69
1/15/202514,970,000 shares $1.66 billion +4.5%0.9%2.7 $110.96
12/31/202414,320,000 shares $1.62 billion +18.4%0.8%2.9 $113.11
12/15/202412,100,000 shares $1.37 billion -10.8%0.7%2.4 $113.38
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
11/30/202413,570,000 shares $1.61 billion +12.6%0.8%2.7 $118.77
11/15/202412,050,000 shares $1.40 billion -14.4%0.7%2.4 $115.90
10/31/202414,070,000 shares $1.60 billion +0.6%0.8%2.9 $113.39
10/15/202413,980,000 shares $1.62 billion +18.2%0.8%2.5 $116.04
9/30/202411,830,000 shares $1.35 billion -11.5%0.7%2 $114.01
9/15/202413,360,000 shares $1.56 billion +4.8%0.8%2.2 $116.40
8/31/202412,750,000 shares $1.44 billion +0.6%0.7%2.1 $113.27
8/15/202412,680,000 shares $1.41 billion -7.0%0.7%2 $110.95
7/31/202413,630,000 shares $1.44 billion +26.8%0.8%2 $105.96
7/15/202410,750,000 shares $1.11 billion -17.3%0.6%1.8 $102.99
6/30/202413,000,000 shares $1.35 billion +11.9%0.8%2.3 $103.91
6/15/202411,620,000 shares $1.20 billion -19.9%0.7%2 $103.68
5/31/202414,500,000 shares $1.48 billion -1.8%0.8%2.4 $102.22
5/15/202414,770,000 shares $1.54 billion +2.0%0.9%2.6 $104.56
4/30/202414,480,000 shares $1.53 billion +11.9%0.8%2.6 $105.94
4/15/202412,940,000 shares $1.41 billion -10.6%0.8%2.2 $108.89
3/31/202414,480,000 shares $1.65 billion -7.9%0.8%2.5 $113.66
3/15/202415,720,000 shares $1.80 billion +5.4%0.9%2.9 $114.43
2/29/202414,920,000 shares $1.77 billion +4.4%0.9%3 $118.56
2/15/202414,290,000 shares $1.62 billion +12.5%0.8%2.7 $113.64
1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16
1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92
12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07
12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29
11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30
11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00
10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55
10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87
9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85
9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76
8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90
8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93
7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34
7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93
6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02
6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04
5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00
5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84
4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47
4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96
3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26
3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80
2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72
2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28
1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55
1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51
12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79
12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52
11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58
11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94
10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91
9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76
9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06
8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65
8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90
7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84
7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82
6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65
6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80
5/31/202213,670,000 shares $1.61 billion +0.7%0.8%2.6 $117.46
5/15/202213,570,000 shares $1.49 billion +0.8%0.8%2.4 $109.88
4/30/202213,460,000 shares $1.53 billion +5.2%0.8%2.5 $113.50
4/15/202212,790,000 shares $1.51 billion +5.7%0.7%2.1 $117.69
3/31/202212,100,000 shares $1.43 billion -9.2%0.7%2 $118.36
3/15/202213,330,000 shares $1.57 billion +28.4%0.8%2.2 $117.48
2/28/202210,380,000 shares $1.25 billion +0.1%0.6%1.6 $120.62
2/15/202210,370,000 shares $1.29 billion +15.4%0.6%1.7 $123.98
1/31/20228,990,000 shares $1.15 billion -0.2%0.5%1.5 $127.46
1/15/20229,010,000 shares $1.15 billion +7.4%0.5%1.6 $128.16
12/31/20218,390,000 shares $1.18 billion -13.3%0.5%1.6 $140.74
12/15/20219,680,000 shares $1.31 billion +11.1%0.6%1.8 $135.56
11/30/20218,710,000 shares $1.10 billion -14.1%0.5%1.7 $125.77
11/15/202110,140,000 shares $1.31 billion -9.7%0.6%2 $129.44
10/29/202111,230,000 shares $1.45 billion +7.0%N/A2.3 $128.89
10/15/202110,500,000 shares $1.23 billion -6.4%0.6%2.3 $117.49
9/30/202111,220,000 shares $1.33 billion +1.5%0.6%2.4 $118.13
9/15/202111,050,000 shares $1.41 billion +8.1%0.6%2.4 $127.49
8/31/202110,220,000 shares $1.29 billion -7.0%0.6%2.1 $126.37

ABT Short Interest - Frequently Asked Questions

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 22,624,184 shares of ABT short. 1.31% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 1.7. Learn More on Abbott Laboratories's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of Abbott Laboratories' floating shares are currently sold short.

Abbott Laboratories saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 22,624,184 shares, a decline of 8.9% from the previous total of 24,846,147 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.31% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies compare to Abbott Laboratories: DexCom, Inc. (4.66%), Intuitive Surgical, Inc. (1.89%), Tesla, Inc. (2.17%), AbbVie Inc. (1.28%), Boston Scientific Corporation (1.54%), Elevance Health, Inc. (2.58%), Integer Holdings Corporation (10.99%), Johnson & Johnson (1.06%), Medtronic PLC (1.42%), Thermo Fisher Scientific Inc. (1.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading up $2.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ABT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:ABT is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel